HomeLYRA • OTCMKTS
add
Lyra Therapeutics Inc
Previous close
$0.53
Day range
$0.53 - $0.65
Year range
$0.31 - $37.50
Market cap
1.15M USD
Avg Volume
97.91K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 7.00K | -96.65% |
Operating expense | 19.94M | -56.66% |
Net income | -6.95M | 36.69% |
Net profit margin | -99.30K | -1,790.31% |
Earnings per share | — | — |
EBITDA | -6.81M | 29.16% |
Effective tax rate | -0.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.89M | -60.83% |
Total assets | 36.11M | -45.58% |
Total liabilities | 46.82M | -14.48% |
Total equity | -10.72M | — |
Shares outstanding | 1.77M | — |
Price to book | -0.09 | — |
Return on assets | -43.29% | — |
Return on capital | -74.16% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -6.95M | 36.69% |
Cash from operations | -6.07M | 46.56% |
Cash from investing | -96.00K | -100.34% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -6.16M | -136.73% |
Free cash flow | -3.26M | 45.90% |
About
Founded
2005
Headquarters
Website
Employees
27
